These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 29898219

  • 1. Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry.
    Nanna MG, Navar AM, Zakroysky P, Xiang Q, Goldberg AC, Robinson J, Roger VL, Virani SS, Wilson PWF, Elassal J, Lee LV, Wang TY, Peterson ED.
    JAMA Cardiol; 2018 Aug 01; 3(8):739-748. PubMed ID: 29898219
    [Abstract] [Full Text] [Related]

  • 2. Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry.
    Nanna MG, Navar AM, Wang TY, Li S, Virani SS, Li Z, Robinson JG, Roger VL, Wilson PWF, Goldberg AC, Koren A, Louie MJ, Peterson ED.
    Am Heart J; 2019 Aug 01; 214():113-124. PubMed ID: 31202098
    [Abstract] [Full Text] [Related]

  • 3. Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry.
    Bradley CK, Wang TY, Li S, Robinson JG, Roger VL, Goldberg AC, Virani SS, Louie MJ, Lee LV, Peterson ED, Navar AM.
    J Am Heart Assoc; 2019 Apr 02; 8(7):e011765. PubMed ID: 30913959
    [Abstract] [Full Text] [Related]

  • 4. Sex Differences in the Use of Statins in Community Practice.
    Nanna MG, Wang TY, Xiang Q, Goldberg AC, Robinson JG, Roger VL, Virani SS, Wilson PWF, Louie MJ, Koren A, Li Z, Peterson ED, Navar AM.
    Circ Cardiovasc Qual Outcomes; 2019 Aug 02; 12(8):e005562. PubMed ID: 31416347
    [Abstract] [Full Text] [Related]

  • 5. Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry).
    Lowenstern A, Navar AM, Li S, Virani SS, Goldberg AC, Louie MJ, Lee LV, Peterson ED, Wang TY.
    Am J Cardiol; 2019 Apr 01; 123(7):1011-1018. PubMed ID: 30660354
    [Abstract] [Full Text] [Related]

  • 6. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
    Nanna MG, Navar AM, Wang TY, Mi X, Virani SS, Louie MJ, Lee LV, Goldberg AC, Roger VL, Robinson J, Peterson ED.
    J Am Heart Assoc; 2018 May 08; 7(10):. PubMed ID: 29739801
    [Abstract] [Full Text] [Related]

  • 7. Measurement of Low-Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry.
    Lowenstern AM, Li S, Navar AM, Roger VL, Robinson JG, Goldberg AC, Virani SS, Lee LV, Wilson PWF, Louie MJ, Peterson ED, Wang TY.
    J Am Heart Assoc; 2018 Sep 18; 7(18):e009251. PubMed ID: 30371214
    [Abstract] [Full Text] [Related]

  • 8. Ethnic differences in guideline-indicated statin initiation for people with type 2 diabetes in UK primary care, 2006-2019: A cohort study.
    Eastwood SV, Mathur R, Sattar N, Smeeth L, Bhaskaran K, Chaturvedi N.
    PLoS Med; 2021 Jun 18; 18(6):e1003672. PubMed ID: 34185782
    [Abstract] [Full Text] [Related]

  • 9. Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry.
    Xian Y, Navar AM, Li S, Li Z, Robinson J, Virani SS, Louie MJ, Koren A, Goldberg A, Roger VL, Wilson PWF, Peterson ED, Wang TY.
    J Am Heart Assoc; 2019 Oct 18; 8(19):e013229. PubMed ID: 31554462
    [Abstract] [Full Text] [Related]

  • 10. Disparities in Guideline-Recommended Statin Use for Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and Gender : A Nationally Representative Cross-Sectional Analysis of Adults in the United States.
    Frank DA, Johnson AE, Hausmann LRM, Gellad WF, Roberts ET, Vajravelu RK.
    Ann Intern Med; 2023 Aug 18; 176(8):1057-1066. PubMed ID: 37487210
    [Abstract] [Full Text] [Related]

  • 11. Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry.
    Lowenstern A, Li S, Navar AM, Virani S, Lee LV, Louie MJ, Peterson ED, Wang TY.
    Am Heart J; 2018 Jun 18; 200():118-124. PubMed ID: 29898839
    [Abstract] [Full Text] [Related]

  • 12. Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry.
    Navar AM, Wang TY, Li S, Robinson JG, Goldberg AC, Virani S, Roger VL, Wilson PWF, Elassal J, Lee LV, Peterson ED.
    Am Heart J; 2017 Nov 18; 193():84-92. PubMed ID: 29129260
    [Abstract] [Full Text] [Related]

  • 13. Race-Sex Differences in Statin Use and Low-Density Lipoprotein Cholesterol Control Among People With Diabetes Mellitus in the Reasons for Geographic and Racial Differences in Stroke Study.
    Gamboa CM, Colantonio LD, Brown TM, Carson AP, Safford MM.
    J Am Heart Assoc; 2017 May 10; 6(5):. PubMed ID: 28490523
    [Abstract] [Full Text] [Related]

  • 14. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F, Maron DJ, Knowles JW, Virani SS, Lin S, Heidenreich PA.
    JAMA Cardiol; 2017 Jan 01; 2(1):47-54. PubMed ID: 27829091
    [Abstract] [Full Text] [Related]

  • 15. Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System.
    Dorsch MP, Lester CA, Ding Y, Joseph M, Brook RD.
    J Am Heart Assoc; 2019 Nov 19; 8(22):e014709. PubMed ID: 31707943
    [Abstract] [Full Text] [Related]

  • 16. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
    Virani SS, Kennedy KF, Akeroyd JM, Morris PB, Bittner VA, Masoudi FA, Stone NJ, Petersen LA, Ballantyne CM.
    Circ Cardiovasc Qual Outcomes; 2018 May 19; 11(5):e004652. PubMed ID: 29748356
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
    Yao X, Shah ND, Gersh BJ, Lopez-Jimenez F, Noseworthy PA.
    JAMA Netw Open; 2020 Nov 02; 3(11):e2025505. PubMed ID: 33216139
    [Abstract] [Full Text] [Related]

  • 19. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide.
    Pokharel Y, Tang F, Jones PG, Nambi V, Bittner VA, Hira RS, Nasir K, Chan PS, Maddox TM, Oetgen WJ, Heidenreich PA, Borden WB, Spertus JA, Petersen LA, Ballantyne CM, Virani SS.
    JAMA Cardiol; 2017 Apr 01; 2(4):361-369. PubMed ID: 28249067
    [Abstract] [Full Text] [Related]

  • 20. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Qureshi WT, Kaplan RC, Swett K, Burke G, Daviglus M, Jung M, Talavera GA, Chirinos DA, Reina SA, Davis S, Rodriguez CJ.
    J Am Heart Assoc; 2017 May 11; 6(5):. PubMed ID: 28495699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.